Clearmind Medicine reports higher nasal tissue retention for intranasal MEAI in ex vivo study
CMND•Ex vivo study shows higher nasal tissue retention
Clearmind Medicine reported positive ex vivo retention results for an intranasal formulation of MEAI, supporting its development program for Alcohol Use Disorder.
Results have already been presented, showing the mucoadhesive formulation stayed associated with nasal tissue longer than a standard MEAI solution.
The company is positioning the intranasal approach to improve absorption consistency, a key step toward differentiated dosing for high-need indications.
